Combination therapy of lamivudine and interferon-alpha in pediatric patients with chronic hepatitis B in Bangladesh: a safe and effective therapeutic approach for pediatric CHB patients in developing countries

International Journal of Immunopathology and Pharmacology
M Al-MahtabF Ahmed

Abstract

Hepatitis B virus (HBV) is mainly transmitted during birth or perinatal period, however, treatment is not usually recommended for pediatric patients with chronic hepatitis B (CHB). Twelve pediatric patients with CHB in Bangladesh were treated with both lamivudine and interferon. Lamivudine was given at a dose of 3 mg/kg, daily for 12 months. Two months after commencement of lamivudine therapy, all patents were given interferon-alpha (3 million IU/square meter of body surface area) three times weekly, subcutaneously for 10 months. Combination therapy was safe for all pediatric CHB patients. The levels of serum HBV DNA became undetectable (less than 500 copies/ml) in 8 patients and reduced in 4 patients after the end of therapy. Anti-HBe was detected in 10 of 12 patients at this time point. The levels of serum alanine aminotransferase (ALT) were significantly reduced in these patients (p less than 0.05) due to therapy. Neither flare of HBV DNA nor elevation of serum ALT were detected during follow-up. In conclusion, combination therapy with lamivudine and interferon-alpha represents a new and novel therapeutic option for treatment of pediatric CHB patients.

References

May 31, 2002·The New England Journal of Medicine·Maureen M JonasUNKNOWN International Pediatric Lamivudine Investigator Group
Mar 5, 2003·Seminars in Liver Disease·Giovanna Fattovich
Mar 12, 2004·The New England Journal of Medicine·Don Ganem, Alfred M Prince
Jan 11, 2005·Lancet·Harry L A JanssenUNKNOWN Rotterdam Foundation for Liver Research
Jan 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Norio HoriikeMorikazu Onji
Jul 1, 2005·The New England Journal of Medicine·George K K LauUNKNOWN Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
Jul 1, 2005·The New England Journal of Medicine·Anna Suk-Fong Lok
Jan 28, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Etienne M SokalMaureen M Jonas
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert P Perrillo
Oct 13, 2006·Journal of Pediatric Gastroenterology and Nutrition·Corina HartmanRaanan Shamir
Nov 22, 2007·Journal of Pediatric Gastroenterology and Nutrition·Zarife KulogluNurten Girgin
Jan 29, 2008·Recent Patents on Anti-infective Drug Discovery·Aydan Kansu
Apr 10, 2008·Liver International : Official Journal of the International Association for the Study of the Liver·Hong-Yuan HsuMei-Hwei Chang
Jul 19, 2008·Journal of Gastroenterology and Hepatology·James FungMan-Fung Yuen
Feb 13, 2009·Expert Review of Gastroenterology & Hepatology·Amethyst C Kurbegov, Ronald J Sokol

❮ Previous
Next ❯

Citations

Jan 1, 2015·Euroasian Journal of Hepato-gastroenterology·Mamun-Al Mahtab

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Ming-fang CuiFei Su
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Jun-ping ShiYun-hao Xun
Liver International : Official Journal of the International Association for the Study of the Liver
Shahinul AlamMobin Khan
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology
Chuan-Tong Lu, Guo-Sheng Gao
© 2021 Meta ULC. All rights reserved